Interleukin-6 is a better metabolic biomarker than interleukin-18 in young healthy adults

Journal of Physiology and Biochemistry

Volumn 71, Issue 3, 2015, Pages 527-535

  Carraro, Júlia Cristina Cardoso ^a   Hermsdorff, Helen Hermana M ^a   Puchau, Blanca ^b   Zulet, M Ángeles ^b,c   Milagro, Fermín I ^b,c   Bressan, Josefina ^a   Martínez, J Alfredo ^b,c  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^b UNIVERSITY OF NAVARRA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; CYTOKINE; INSULIN; INTERLEUKIN 18; INTERLEUKIN 6; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN; INTERLEUKIN 18 PROTEIN, HUMAN;

ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY FAT DISTRIBUTION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPOTHALAMUS; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE; MALE; METABOLIC DISORDER; OBESITY; PHYSICAL ACTIVITY; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; YOUNG ADULT; ADOLESCENT; BLOOD; COMPARATIVE STUDY; METABOLIC DISEASES; NORMAL HUMAN; STATISTICAL MODEL;

ADOLESCENT; ADULT; BIOMARKERS; BODY FAT DISTRIBUTION; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INTERLEUKIN-18; INTERLEUKIN-6; LINEAR MODELS; MALE; METABOLIC DISEASES; YOUNG ADULT;

EID: 84939463979     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-015-0391-2     Document Type: Article

References (47)

1. Ahmad R, Al-Mass A, Al-Ghawas D et al (2013) Interaction of osteopontin with IL-18 in obese individuals: implications for insulin resistance. PLoS ONE 8(5):e63944
2. Blackburn P, Després J-P, Lamarche B et al (2006) Postprandial variations of plasma inflammatory markers in abdominally obese men. Obesity 14(10):1747–1754
3. Blankenberg S, Luc G, Ducimetière P et al (2003) Interleukin-18 and the risk of coronary heart disease in European men: the prospective epidemiological study of myocardial infarction (PRIME). Circulation 108(20):2453–2459
4. Bondia-Pons I, Ryan L, Martinez JA (2012) Oxidative stress and inflammation interactions in human obesity. J Physiol Biochem 68(4):701–711
5. Breyer MK, Rutten EPA, Vernooy JHJ, Spruit MA, Dentener MA, van der Kallen C, vanGreevenbroek MMJ, Wouters EFM (2011) Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin. Respir Med 105:1046–1053
6. Bruun J, Stallknecht B, Helge J, Richelsen B (2007) Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss. Eur J Endocrinol 157:465–471
7. Chen YC, Chen SD, Miao L, Liu ZG, Li W, Zhao ZX, Sun XJ, Jiang GX, Cheng Q (2012) Serum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with multiple sclerosis. J Neuroimmunol 243(1–2):56–60
8. Ching PL, Willett WC, Rimm EB et al (1996) Activity level and risk of overweight in male health professionals. Am J Public Health 86(1):25–30
9. Diehl S, Rincón M (2002) The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 39(9):531–536
10. Dinarello CA (1999) IL-18: A TH1 -inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 103(1):11–24
11. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115(5):911–919
12. Gerdes N, Sukhova GK, Libby P et al (2002) Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 195:245–257
13. Goyenechea E, Parra D, Martínez JA (2007) Impact of interleukin 6–174G > C polymorphism on obesity-related metabolic disorders in people with excess in body weight. Metabolism 56(12):1643–1648
14. Gülçubuk A, Haktanir D, Cakiris A et al (2014) The effects of resveratrol on tissue injury, oxidative damage, and pro-inflammatory cytokines in an experimental model of acute pancreatitis. J Physiol Biochem 70(2):397–406
15. Gustafson B, Hammarstedt A, Andersson CX et al (2007) Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 27(11):2276–2283
16. Helmersson J, Larsson A, Vessby B, Basu S (2005) Active smoking and a history of smoking are associated with enhanced prostaglandin F2α, interleukin-6 and F2-isoprostane formation in elderly men. Atherosclerosis 181(1):201–207
17. Hermsdorff H, Zulet MA, Abete I, Martínez JA (2011) A legume-based hypocaloric diet reduces proinflammatory status and improves metabolic features in overweight/obese subjects. Eur J Nutr 50(1):61–69
18. Hermsdorff H, Zulet MA, Puchau B, Martínez JA (2011) Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation 34(3):161–170
19. Hermsdorff HH, Zulet MA, Martínez JA (2011) The implication of unknown bioactive compounds and cooking techniques in relations between the variety in fruit and vegetable intake and inflammation. Am J Clin Nutr 93(6):1384
20. Hermsdorff HHM, Puchau B, Bressan J, Martínez JA (2009) Association of retinol-binding protein-4 with dietary selenium intake and other lifestyle features in young healthy women. Nutrition 25(4):392–399
21. Hermsdorff HHM, Puchau B, Bressan J, Martínez JA (2010) Association of body Fat distribution with proinflammatory gene expression in peripheral blood mononuclear cells from young adult subjects. OMICS: J Integr Biol 14(3):297–307
22. Hung J, McQuillan BM, Chapman CML (2005) Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol 25(6):1268–1273
23. Kim T, Choi S, Ha E et al (2013) IL-6 induction of TLR-4 gene expression via STAT3 has an effect on insulin resistance in human skeletal muscle. Acta Diabetol 50(2):189–200
24. Lavie CJ, Church TS, Milani RV, Earnest CP (2011) Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation. J Cardiopulm Rehabil Prev 31(3):137–145
25. Matthews DR, Hosker JP, Rudenski AS, Nayloret BA et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–9
26. McCarty MF (1999) Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, athanol and pentoxifylline. Med Hypotheses 52(5):465–477
27. Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454(7203):428–435
28. Moreno-Aliaga M, Campión J, Milagro FI et al (2005) Adiposity and proinflammatory state: the chicken or the egg. Adipocytes 1:1–16
29. Netea MG, Joosten LAB, Lewis E et al (2006) Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med 12(6):650–656
30. Opstad TB, Pettersen AA, Arnesen H, Seljeflot I (2011) Circulating levels of IL-18 are significantly influenced by the IL-18 + 183 A/g polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study. Cardiovasc Diabetol 10:110
31. Pannacciulli N, Cantatore FP, Minenna A et al (2001) C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. International journal of obesity and related metabolic disorders. Int J Obes Relat Metab Disord 25(10):1416–1420
32. Pedersen M, Bruunsgaard H, Weis N et al (2003) Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech Ageing Dev 124(4):495–502
33. Petersen AMW, Pedersen BK (2006) The role of il-6 in mediating the anti-inflammatory effects of exercise. J Physiol Pharmacol 57(10):43–51
34. Quintero P, Milagro FI, Campion J, Martínez JA (2010) Impact of oxygen availability on body weight management. Med Hypotheses 74(5):901–907
35. Ropelle ER, Flores MB, Cintra DE et al (2010) IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKβ and ER stress inhibition. PLoS Biol 8(8):e1000465
36. Safavi SM, Ziaei R, Marac MR (2012) Association of serum ceruloplasmin level with obesity: some components of metabolic syndrome and high-sensitive C-reactive protein in Iran. J Obes 2012:951093
37. Simental-Mendía L, Rodríguez-Morán M, Guerrero-Romero F (2008) The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6:299–304
38. Thaler JP, Schwartz MW (2010) Minireview: inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology 151(9):4109–4115
39. Vachharajani V, Granger DN (2009) Adipose tissue: a motor for the inflammation associated with obesity. IUBMB Life 61(4):424–430
40. Vasques ACJ, Novaes FS, de Oliveira MS et al (2011) TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract 93(3):e98–e100
41. Wang B, Li Q, Jiang Y et al (2011) Serum complement C3 has a stronger association with insulin resistance than high sensitive C-reactive protein in non-diabetic Chinese. Inflamm Res 60(1):63–68
42. Whitworth JA, Chalmers J (2004) World health organisation-international society of hypertension (WHO/ISH) hypertension guidelines. Clin Exp Hypertens 26(7–8):747–52
43. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19(4):972–978
44. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V (2000) Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148(2):209–214
45. Zilverschoon GRC, Tack CJ, Joosten LAB et al (2008) Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus. Int J Obes 32(9):1407–1414
46. Zorrilla EP, Sanchez-Alavez M, Sugama S et al (2007) Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc Natl Acad Sci U S A 104(26):11097–11102
47. Zulet MA, Puchau B, Navarro C et al (2007) Biomarcadores del estado inflamatorio: nexo de unión con la obesidad y complicaciones asociadas. Nutr Hosp 22(5):511–527